1-9 of 9
Christoph Schaniel
Close
Sort by
Journal Articles

A Dual-Specific Inhibitor of Rock/Aurk, RR-1752, for Primary Myelofibrosis

Liqiang Zhang, Kathryn McGinnis, Paul Gonzales, Maggie Murray, Emily Cluff, MD Babu Mia, Christoph Schaniel, Joseph Mascarenhas, Alan M Miller, Ronald Hoffman, Stephen Gately
Journal: Blood
Blood (2023) 142 (Supplement 1): 4529.
https://doi.org/10.1182/blood-2023-182046
Published: 2023
Journal Articles

Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy

Santiago Thibaud, Md. Babu Mia, Oliver Van Oekelen, Tarek H. Mouhieddine, Christoph Schaniel, Yogita Ghodke-Puranik, Adolfo Aleman, Bhaskar Upadhyaya, Guido Lancman, Alessandro Lagana, Shambavi Richard, Adriana Rossi, Ajai Chari, Larysa Sanchez, Cesar Rodriguez, Hearn J. Cho, Joshua Richter, Ronald Hoffman, Sundar Jagannath, Samir Parekh
Journal: Blood
Blood (2022) 140 (Supplement 1): 614–616.
https://doi.org/10.1182/blood-2022-165646
Published: 2022
Journal Articles

Co-Cultivation of MF CD34+ Cells with Microenvironmental Cells Has a Profound Effect on MF Hematopoiesis and Responses to Drug Therapy

Min Lu, Christoph Schaniel, Jeff Vierstra, Lijuan Xia, Ronald Hoffman
Journal: Blood
Blood (2022) 140 (Supplement 1): 8625–8626.
https://doi.org/10.1182/blood-2022-170704
Published: 2022
Journal Articles

Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis

Bridget K Marcellino, Cara Clementelli, Kristin Beaumont, Christoph Schaniel, Min Lu, Karie Chen, Adena Russel, Ayman Mohammad, Daniel I Nathan, Jake Aronin, Alan H. Shih, Robert Sebra, Ronald Hoffman
Journal: Blood
Blood (2022) 140 (Supplement 1): 797–798.
https://doi.org/10.1182/blood-2022-170232
Published: 2022
Journal Articles

Distinct Mechanisms Underlying the Ex Vivo Expansion of Human Cord Blood Stem Cells with Different Strategies Currently Used for Allogeneic Transplantation

Luena Papa, PhD, Mansour Djedaini, BS, Christoph Schaniel, PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4470.
https://doi.org/10.1182/blood-2019-127040
Published: 2019
Journal Articles

Wnt-inhibitory factor 1 dysregulation of the bone marrow niche exhausts hematopoietic stem cells

Christoph Schaniel, Dario Sirabella, Jiajing Qiu, Xiaohong Niu, Ihor R. Lemischka, Kateri A. Moore
Journal: Blood
Blood (2011) 118 (9): 2420–2429.
https://doi.org/10.1182/blood-2010-09-305664
Published: 2011
Includes: Supplemental data
Journal Articles

Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5 -deficient precursor B-cell clones

Christoph Schaniel, Marie Gottar, Eddy Roosnek, Fritz Melchers, Antonius G. Rolink
Journal: Blood
Blood (2002) 99 (8): 2760–2766.
https://doi.org/10.1182/blood.V99.8.2760
Published: 2002
Journal Articles

Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5 -deficient pre-B I–cell clones

Christoph Schaniel, Ludovica Bruno, Fritz Melchers, Antonius G. Rolink
Journal: Blood
Blood (2002) 99 (2): 472–478.
https://doi.org/10.1182/blood.V99.2.472
Published: 2002
Journal Articles

Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells

Paolo Ghia, Pietro Transidico, J. Pedro Veiga, Christoph Schaniel, Federica Sallusto, Kouji Matsushima, Stephen E. Sallan, Antonius G. Rolink, Alberto Mantovani, Lee M. Nadler, Angelo A. Cardoso
Journal: Blood
Blood (2001) 98 (3): 533–540.
https://doi.org/10.1182/blood.V98.3.533
Published: 2001